Cargando…
Effects of Amyloid Precursor Protein 17 Peptide on the Protection of Diabetic Encephalopathy and Improvement of Glycol Metabolism in the Diabetic Rat
Researchers have proposed that amyloid precursor protein 17 peptide (APP17 peptide), an active fragment of amyloid precursor protein (APP) in the nervous system, has therapeutic effects on neurodegeneration. Diabetic encephalopathy (DE) is a neurological disease caused by diabetes. Here we use multi...
Autores principales: | Meng, Heng, Zhang, Duo, Yang, Haishan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703363/ https://www.ncbi.nlm.nih.gov/pubmed/23844373 http://dx.doi.org/10.1155/2013/689841 |
Ejemplares similares
-
Role of the Insulin-Like Growth Factor Type 1 Receptor in the Pathogenesis of Diabetic Encephalopathy
por: Zhang, Duo, et al.
Publicado: (2015) -
Ethylene glycol toxic encephalopathy
por: Santana-Cabrera, Luciano, et al.
Publicado: (2013) -
Autophagy is involved in oligodendroglial precursor-mediated clearance of amyloid peptide
por: Li, Wenxia, et al.
Publicado: (2013) -
Analysis of Metabolic Alterations Related to Pathogenic Process of Diabetic Encephalopathy Rats
por: Dong, Minjian, et al.
Publicado: (2019) -
The Effects of C-peptide on Type 1 Diabetic Polyneuropathies and Encephalopathy
in the BB/Wor-rat
por: Sima, Anders A. F., et al.
Publicado: (2008)